John Overdeck’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.1K Sell
36,365
-50,605
-58% -$61.8K ﹤0.01% 4959
2026
Q1
$117K Sell
86,970
-780,849
-90% -$1.16M ﹤0.01% 4369
2025
Q4
$1.46M Buy
867,819
+421,127
+94% +$724K ﹤0.01% 2683
2025
Q3
$907K Buy
+446,692
New +$702K ﹤0.01% 2649
2025
Q1
Sell
-130,477
Closed -$210K 3406
2024
Q4
$210K Sell
130,477
-189,007
-59% -$308K ﹤0.01% 2865
2024
Q3
$578K Buy
319,484
+201,871
+172% +$351K ﹤0.01% 2399
2024
Q2
$181K Buy
117,613
+105,332
+858% +$191K ﹤0.01% 2748
2024
Q1
$26.4K Sell
12,281
-71,727
-85% -$139K ﹤0.01% 2919
2023
Q4
$110K Buy
+84,008
New +$103K ﹤0.01% 2931
2022
Q3
Sell
-19,897
Closed -$73K 2711
2022
Q2
$73K Sell
19,897
-286,674
-94% -$1.46M ﹤0.01% 2309
2022
Q1
$2.04M Sell
306,571
-479,386
-61% -$2.96M 0.01% 1349
2021
Q4
$5.5M Buy
+785,957
New +$6.67M 0.01% 1144
2021
Q3
Sell
-206,294
Closed -$2.36M 4565
2021
Q2
$2.36M Buy
+206,294
New +$2.35M 0.01% 1735
2020
Q1
Sell
-30,318
Closed -$297K 3636
2019
Q4
$297K Buy
+30,318
New +$358K ﹤0.01% 3195

Other funds holding OGI

John Overdeck's OGI Position: Q2 2026 in Review

John Overdeck reduced its Organigram Holdings (OGI) stake by 58% in Q2 2026, selling an estimated $61.8K and leaving 36,365 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4959.

John Overdeck first reported a position in OGI in Q4 2019 and has held it in 14 quarters since. The position peaked at $5.5M in Q4 2021. 70 funds tracked by Wall St. Rank hold OGI as of Q2 2026.

  • John Overdeck held 36,365 shares of Organigram Holdings worth $37.1K as of Q2 2026.
  • John Overdeck sold 50,605 Organigram Holdings shares in Q2 2026, an estimated $61.8K.
  • Organigram Holdings made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4959 holding.
  • John Overdeck first reported a position in Organigram Holdings in Q4 2019 and has held it in 14 quarters since.
  • John Overdeck's Organigram Holdings position peaked at $5.5M in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Organigram Holdings as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.